Sarvamangal Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-06-2024
- Paid Up Capital ₹ 0.18 M
as on 24-06-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 24-06-2024
- Revenue 38.77%
(FY 2020)
- Profit 95.40%
(FY 2020)
- Ebitda 53.69%
(FY 2020)
- Net Worth 74.81%
(FY 2020)
- Total Assets 36.21%
(FY 2020)
About Sarvamangal Healthcare
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹1.00 M.
Anil Kulkarni, Aniruddha Kulkarni, Anushree Kulkarni, and Four other members serve as directors at the Company.
- CIN/LLPIN
U33120PN2011PTC139475
- Company No.
139475
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sarvamangal Healthcare?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniruddha Kulkarni  | Director | 09-May-2011 | Current |
| Anil Kulkarni | Director | 09-May-2011 | Current |
| Abhijit Kulkarni | Director | 01-Mar-2012 | Current |
| Anushree Kulkarni | Director | 09-May-2011 | Current |
| Nutan Kulkarni | Director | 01-Mar-2012 | Current |
| Pushkar Ulhas | Director | 01-Mar-2012 | Current |
Financial Performance and Corporate Structure Insights of Sarvamangal Healthcare.
Sarvamangal Healthcare Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 38.77% increase. The company also saw a substantial improvement in profitability, with a 95.4% increase in profit. The company's net worth Soared by an impressive increase of 74.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sarvamangal Healthcare?
In 2019, Sarvamangal Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Advaitech Innovations Private Limited
Active
7 months 6 days Aniruddha Kulkarni and Anushree Kulkarni are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jul 2021 | ₹1.00 M | Open |
How Many Employees Work at Sarvamangal Healthcare?
Unlock and access historical data on people associated with Sarvamangal Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Nov 06, 2013, Sarvamangal Healthcare has raised a total of ₹ 75 K, with the most recent deal valued at ₹ 75 K. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
